Dr. Reddy's Lab soars on launching Hydroxychloroquine Sulfate Tablets in US market

12 Jul 2018 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2361.70, up by 59.00 points or 2.56% from its previous closing of Rs. 2302.70 on the BSE.

The scrip opened at Rs. 2325.00 and has touched a high and low of Rs. 2386.90 and Rs. 2325.00 respectively. So far 122713 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2788.00 on 24-Jul-2017 and a 52 week low of Rs. 1888.00 on 21-May-2018.

Last one week high and low of the scrip stood at Rs. 2398.00 and Rs. 2256.30 respectively. The current market cap of the company is Rs. 39209.75 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 45.05% and 28.18% respectively.

Dr. Reddy's Laboratories has launched Hydroxychloroquine Sulfate Tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil Tablets, in the US market, approved by the US Food and Drug Administration (USFDA).

The Plaquenil brand and generic had US sales of approximately $215 million MAT for the most recent twelve months ending in May 2018 according to IMS Health. The company’s Hydroxychloroquine Sulfate Tablets are available in 200 mg tablets in the bottle count sizes of 100 and 500. Plaquenil is a trademark of Concordia International Corp.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1166.45 -9.10 (-0.77%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×